Limit Opioids for Acute Pain...to Decrease Risk of Long-Term Use

You'll see stronger efforts to limit opioid use for pain...due to new FDA warnings and CDC prescribing guidelines.

Product labeling will contain new, FDA-required boxed warnings for SHORT-acting opioids about abuse, overdose, etc...similar to those already in place for LONG-acting opioids.

CDC also now recommends limiting opioid doses and durations. This will lead to changes with insurers, quality measures, etc.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: PA includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote